

The term industrial microbiology refers to the use of microorganisms for industrial purposes. Such things as anticoagulants, antidepressants, vasodilators, herbicides, insecticides, plant hormones, enzymes, and vitamins have been isolated from microorganisms or produced in large quantities by genetically engineering the organisms with foreign genes.
Highlights
The global Microbial Products market was valued at US$ 171560 million in 2022 and is anticipated to reach US$ 262210 million by 2029, witnessing a CAGR of 5.8% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
In commercial industrial plants, microorganisms are widely used to produce numerous organic materials that have far-reaching value and application, including Enzymes, Polysaccharides, Nutrients, Chemotherapeutic Agents, Antibiotics and Vaccines.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microbial Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Products.
The Microbial Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Microbial Products market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Amgen
Merck
Valent BioSciences
GlaxoSmithKline
Pfizer
µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Ajinomoto
Sanofi
Novartis
NovaDigm Therapeutics
Kyowa Hakko Bio
Segment by Type
Enzymes
Polysaccharides
Nutrients
Chemotherapeutic Agents
Antibiotics
Vaccines
Others
Segment by Application
Pharmaceutical
Diagnostic
Biotechnology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microbial Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microbial Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Microbial Products Market Overview
1.1 Product Overview and Scope of Microbial Products
1.2 Microbial Products Segment by Type
1.2.1 Global Microbial Products Market Value Comparison by Type (2023-2029)
1.2.2 Enzymes
1.2.3 Polysaccharides
1.2.4 Nutrients
1.2.5 Chemotherapeutic Agents
1.2.6 Antibiotics
1.2.7 Vaccines
1.2.8 Others
1.3 Microbial Products Segment by Application
1.3.1 Global Microbial Products Market Value by Application: (2023-2029)
1.3.2 Pharmaceutical
1.3.3 Diagnostic
1.3.4 Biotechnology
1.3.5 Others
1.4 Global Microbial Products Market Size Estimates and Forecasts
1.4.1 Global Microbial Products Revenue 2018-2029
1.4.2 Global Microbial Products Sales 2018-2029
1.4.3 Global Microbial Products Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Microbial Products Market Competition by Manufacturers
2.1 Global Microbial Products Sales Market Share by Manufacturers (2018-2023)
2.2 Global Microbial Products Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Microbial Products Average Price by Manufacturers (2018-2023)
2.4 Global Microbial Products Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Microbial Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microbial Products, Product Type & Application
2.7 Microbial Products Market Competitive Situation and Trends
2.7.1 Microbial Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microbial Products Players Market Share by Revenue
2.7.3 Global Microbial Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microbial Products Retrospective Market Scenario by Region
3.1 Global Microbial Products Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Microbial Products Global Microbial Products Sales by Region: 2018-2029
3.2.1 Global Microbial Products Sales by Region: 2018-2023
3.2.2 Global Microbial Products Sales by Region: 2024-2029
3.3 Global Microbial Products Global Microbial Products Revenue by Region: 2018-2029
3.3.1 Global Microbial Products Revenue by Region: 2018-2023
3.3.2 Global Microbial Products Revenue by Region: 2024-2029
3.4 North America Microbial Products Market Facts & Figures by Country
3.4.1 North America Microbial Products Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Microbial Products Sales by Country (2018-2029)
3.4.3 North America Microbial Products Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microbial Products Market Facts & Figures by Country
3.5.1 Europe Microbial Products Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Microbial Products Sales by Country (2018-2029)
3.5.3 Europe Microbial Products Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microbial Products Market Facts & Figures by Country
3.6.1 Asia Pacific Microbial Products Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Microbial Products Sales by Country (2018-2029)
3.6.3 Asia Pacific Microbial Products Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microbial Products Market Facts & Figures by Country
3.7.1 Latin America Microbial Products Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Microbial Products Sales by Country (2018-2029)
3.7.3 Latin America Microbial Products Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microbial Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Microbial Products Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Microbial Products Sales by Country (2018-2029)
3.8.3 Middle East and Africa Microbial Products Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microbial Products Sales by Type (2018-2029)
4.1.1 Global Microbial Products Sales by Type (2018-2023)
4.1.2 Global Microbial Products Sales by Type (2024-2029)
4.1.3 Global Microbial Products Sales Market Share by Type (2018-2029)
4.2 Global Microbial Products Revenue by Type (2018-2029)
4.2.1 Global Microbial Products Revenue by Type (2018-2023)
4.2.2 Global Microbial Products Revenue by Type (2024-2029)
4.2.3 Global Microbial Products Revenue Market Share by Type (2018-2029)
4.3 Global Microbial Products Price by Type (2018-2029)
5 Segment by Application
5.1 Global Microbial Products Sales by Application (2018-2029)
5.1.1 Global Microbial Products Sales by Application (2018-2023)
5.1.2 Global Microbial Products Sales by Application (2024-2029)
5.1.3 Global Microbial Products Sales Market Share by Application (2018-2029)
5.2 Global Microbial Products Revenue by Application (2018-2029)
5.2.1 Global Microbial Products Revenue by Application (2018-2023)
5.2.2 Global Microbial Products Revenue by Application (2024-2029)
5.2.3 Global Microbial Products Revenue Market Share by Application (2018-2029)
5.3 Global Microbial Products Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen Microbial Products Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Microbial Products Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Valent BioSciences
6.3.1 Valent BioSciences Corporation Information
6.3.2 Valent BioSciences Description and Business Overview
6.3.3 Valent BioSciences Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Valent BioSciences Microbial Products Product Portfolio
6.3.5 Valent BioSciences Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Microbial Products Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Microbial Products Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
6.6.1 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Corporation Information
6.6.2 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Description and Business Overview
6.6.3 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.6.4 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Microbial Products Product Portfolio
6.6.5 µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Developments/Updates
6.7 Ajinomoto
6.6.1 Ajinomoto Corporation Information
6.6.2 Ajinomoto Description and Business Overview
6.6.3 Ajinomoto Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ajinomoto Microbial Products Product Portfolio
6.7.5 Ajinomoto Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanofi Microbial Products Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novartis Microbial Products Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 NovaDigm Therapeutics
6.10.1 NovaDigm Therapeutics Corporation Information
6.10.2 NovaDigm Therapeutics Description and Business Overview
6.10.3 NovaDigm Therapeutics Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.10.4 NovaDigm Therapeutics Microbial Products Product Portfolio
6.10.5 NovaDigm Therapeutics Recent Developments/Updates
6.11 Kyowa Hakko Bio
6.11.1 Kyowa Hakko Bio Corporation Information
6.11.2 Kyowa Hakko Bio Microbial Products Description and Business Overview
6.11.3 Kyowa Hakko Bio Microbial Products Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Kyowa Hakko Bio Microbial Products Product Portfolio
6.11.5 Kyowa Hakko Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microbial Products Industry Chain Analysis
7.2 Microbial Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microbial Products Production Mode & Process
7.4 Microbial Products Sales and Marketing
7.4.1 Microbial Products Sales Channels
7.4.2 Microbial Products Distributors
7.5 Microbial Products Customers
8 Microbial Products Market Dynamics
8.1 Microbial Products Industry Trends
8.2 Microbial Products Market Drivers
8.3 Microbial Products Market Challenges
8.4 Microbial Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Amgen
Merck
Valent BioSciences
GlaxoSmithKline
Pfizer
µþ¾±´Ç²Ñé°ù¾±±ð³Ü³æ
Ajinomoto
Sanofi
Novartis
NovaDigm Therapeutics
Kyowa Hakko Bio
Ìý
Ìý
*If Applicable.